Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_3
2
25%
Ph phase_2
5
63%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
5(62.5%)
Phase 3Large-scale testing
2(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 25 (62.5%)
Phase 32 (25.0%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects

NCT06473662
completedphase_2

Fr1da Insulin Intervention

NCT02620072
completedphase_2

GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)

NCT03364868
completedphase_2

A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)

NCT02653300
completedphase_3

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

NCT00419562
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06473662Phase 2

Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects

Completed
NCT02620072Phase 2

Fr1da Insulin Intervention

Completed
NCT03364868Phase 2

GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)

Completed
NCT02653300Phase 2

A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)

Completed
NCT00419562Phase 3

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Completed
NCT00004984Phase 3

The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)

Completed
NCT02547519Phase 2

Pre-POINT-Early Study

Completed
NCT00982254Phase 1

Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes

Completed

All 8 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
8